| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d9072cb25d6ae674a3943f14e5771e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faf522b8b83eded745c73018576219ba |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2005-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b2cf3846f9e94295cc0ba9375ea0294
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfb68bb4fe98d57fede385cf179bac33 |
| publicationDate |
2007-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2007151478-A |
| titleOfInvention |
Compounds for the treatment of neurodegenerative diseases |
| abstract |
Disclosed is a polypeptide or the like for treating conformational disease. A polypeptide comprising a specific amino acid sequence that binds to a conformational disease causative protein and inactivates the pathogenic effect of the protein; a nucleic acid encoding the polypeptide; or such a nucleic acid. A recombinant expression vector or a recombinant virus, which is contained so that it can be expressed. Abnormalities occurring in cells can be recovered by utilizing the molecular mechanism of ALS onset caused by mutant SOD1 protein. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103374071-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103374071-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017217439-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10689394-B2 |
| priorityDate |
2005-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |